| scholarly article | Q13442814 |
| P50 | author | Eva-Maria Mandelkow | Q19971785 |
| P2093 | author name string | B Trinczek | |
| E Mandelkow | |||
| J Biernat | |||
| K Baumann | |||
| P2860 | cites work | Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau | Q24294296 |
| Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262 | Q24313123 | ||
| Tau protein binds to microtubules through a flexible array of distributed weak sites | Q24323891 | ||
| Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics | Q24672791 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| Use of T7 RNA polymerase to direct expression of cloned genes | Q27860692 | ||
| Microtubule bundling by tau proteins in vivo: analysis of functional domains | Q28565528 | ||
| Real-time observations of microtubule dynamic instability in living cells | Q28760164 | ||
| Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease | Q28910345 | ||
| Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure | Q28910456 | ||
| Dynamic instability of microtubule growth | Q29547522 | ||
| Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments | Q33983175 | ||
| Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly | Q34275737 | ||
| Microtubule stabilization by assembly-promoting microtubule-associated proteins: a repeat performance | Q34295712 | ||
| A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule | Q34345777 | ||
| The RII subunit of cAMP-dependent protein kinase binds to a common amino-terminal domain in microtubule-associated proteins 2A, 2B, and 2C. | Q34459577 | ||
| Dynamic instability of individual microtubules analyzed by video light microscopy: rate constants and transition frequencies | Q36219356 | ||
| Effect on microtubule dynamics of XMAP230, a microtubule-associated protein present in Xenopus laevis eggs and dividing cells. | Q36234875 | ||
| Analysis of MAP 4 function in living cells using green fluorescent protein (GFP) chimeras | Q36235827 | ||
| Observation and quantification of individual microtubule behavior in vivo: microtubule dynamics are cell-type specific | Q36383042 | ||
| Control of microtubule dynamics and length by cyclin A- and cyclin B-dependent kinases in Xenopus egg extracts. | Q36531791 | ||
| Phosphorylation determines the binding of microtubule-associated protein 2 (MAP2) to microtubules in living cells | Q36532712 | ||
| Overexpression of tau in a nonneuronal cell induces long cellular processes | Q36532768 | ||
| Microtubule-stabilizing activity of microtubule-associated proteins (MAPs) is due to increase in frequency of rescue in dynamic instability: shortening length decreases with binding of MAPs onto microtubules | Q36715361 | ||
| Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau | Q37057524 | ||
| Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. | Q38310577 | ||
| Dynamics of microtubules from erythrocyte marginal bands | Q40365450 | ||
| Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells. | Q40367128 | ||
| Diverse distribution and function of fibrous microtubule-associated proteins in the nervous system. | Q40623763 | ||
| Tau as a marker for Alzheimer's disease | Q40715014 | ||
| Microtubule organization and dynamics dependent on microtubule-associated proteins | Q40744920 | ||
| Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. | Q41229492 | ||
| Modulation of microtubule dynamic instability in vivo by brain microtubule associated proteins | Q41355675 | ||
| Microtubule-associated protein function: lessons from expression in Spodoptera frugiperda cells | Q41502296 | ||
| Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state | Q41525580 | ||
| The microtubule-binding fragment of microtubule-associated protein-2: location of the protease-accessible site and identification of an assembly-promoting peptide | Q41591267 | ||
| Effects of brain microtubule-associated proteins on microtubule dynamics and the nucleating activity of centrosomes | Q41755037 | ||
| Functional analyses of the domain structure of microtubule-associated protein-4 (MAP-U). | Q42628133 | ||
| Human tau isoforms confer distinct morphological and functional properties to stably transfected fibroblasts | Q42804858 | ||
| Expression of tau protein in non-neuronal cells: microtubule binding and stabilization | Q42819034 | ||
| Identification of tau protein regions required for process formation in PC12 cells. | Q42832295 | ||
| Role of tubulin-associated proteins in microtubule nucleation and elongation | Q44753212 | ||
| New features of microtubule behaviour observed in vivo | Q45299254 | ||
| Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine. | Q46012222 | ||
| Proline-directed phosphorylation of human Tau protein. | Q46151737 | ||
| Real-time visualization of cell cycle-dependent changes in microtubule dynamics in cytoplasmic extracts | Q46212390 | ||
| Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. | Q48253590 | ||
| Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. | Q48394153 | ||
| Brain microtubule-associated proteins modulate microtubule dynamic instability in vitro. Real-time observations using video microscopy | Q48397720 | ||
| Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain | Q48443930 | ||
| Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease | Q48444661 | ||
| Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain. | Q48445955 | ||
| A serine/threonine proline kinase activity is included in the tau protein kinase fraction forming a paired helical filament epitope | Q48687234 | ||
| Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. | Q53317292 | ||
| Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation. | Q54635315 | ||
| Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. | Q54663388 | ||
| Peptides from the Conserved Ends of the Rod Domain of Desmin Disassemble Intermediate Filaments and Reveal Unexpected Structural Features: A Circular Dichroism, Fourier Transform Infrared, and Electron Microscopic Study | Q56936623 | ||
| Direct observation of microtubule dynamics in living cells | Q58982460 | ||
| Visualization of the dynamic instability of individual microtubules by dark-field microscopy | Q59067947 | ||
| Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5 | Q60603655 | ||
| Determination and location of phosphoserine in proteins and peptides by conversion to S-ethylcysteine | Q68047824 | ||
| Microtubules grow and shorten at intrinsically variable rates | Q68101164 | ||
| Two separate 18-amino acid domains of tau promote the polymerization of tubulin | Q69182676 | ||
| Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain | Q70500478 | ||
| Microtubule-associated protein 2 alters the dynamic properties of microtubule assembly and disassembly | Q70695687 | ||
| Domains of tau protein and interactions with microtubules | Q72146653 | ||
| Regulation of microtubule dynamic instability by tubulin-GDP | Q72422650 | ||
| Non-cooperative binding of the MAP-2 microtubule-binding region to microtubules | Q72465600 | ||
| Chapter 23 Preparation and Purification of Dynein | Q72760251 | ||
| Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau | Q72901527 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 1887-1902 | |
| P577 | publication date | 1995-12-01 | |
| P1433 | published in | Molecular Biology of the Cell | Q2338259 |
| P1476 | title | Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules | |
| P478 | volume | 6 |
| Q37695237 | A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy |
| Q37514847 | A functional role for intrinsic disorder in the tau-tubulin complex |
| Q30483440 | A general modeling and visualization tool for comparing different members of a group: application to studying tau-mediated regulation of microtubule dynamics. |
| Q53397875 | A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies |
| Q35006348 | A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function |
| Q49150263 | Acetyl‐L‐Carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol‐3 kinase and protein kinase C |
| Q77458702 | Acute inactivation of tau has no effect on dynamics of microtubules in growing axons of cultured sympathetic neurons |
| Q38122150 | Alzheimers Disease: Review of Emerging Treatment Role for Intravenous Immunoglobulins |
| Q39135430 | An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease |
| Q42714396 | Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition |
| Q38829673 | Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy |
| Q41150186 | Anti-tau antibody reduces insoluble tau and decreases brain atrophy |
| Q34418930 | At the Fulcrum in Health and Disease: Cdk5 and the Balancing Acts of Neuronal Structure and Physiology |
| Q37590635 | Back to the tubule: microtubule dynamics in Parkinson's disease |
| Q34800214 | Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts |
| Q44683581 | Comparative vibrational spectroscopy of intracellular tau and extracellular collagen I reveals parallels of gelation and fibrillar structure |
| Q36677242 | Complementary dimerization of microtubule-associated tau protein: Implications for microtubule bundling and tau-mediated pathogenesis |
| Q28555169 | Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members |
| Q24336244 | Control of Microtubule Dynamics by Oncoprotein 18: Dissection of the Regulatory Role of Multisite Phosphorylation during Mitosis |
| Q34113857 | Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach. |
| Q38807264 | DYRK1A inhibition as potential treatment for Alzheimer's disease. |
| Q28276894 | Dendritic changes in Alzheimer's disease and factors that may underlie these changes |
| Q35234889 | Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease |
| Q51577810 | Direct Observation of Aggregation-Induced Backbone Conformational Changes in Tau Peptides |
| Q42822546 | Domains of Neuronal Microtubule-associated Proteins and Flexural Rigidity of Microtubules |
| Q47070820 | Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. |
| Q35163252 | Drugs that target dynamic microtubules: A new molecular perspective |
| Q24339549 | Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Modulates Serine/Arginine-rich Protein 55 (SRp55)-promoted Tau Exon 10 Inclusion |
| Q37845025 | Emerging themes of cAMP regulation of the pulmonary endothelial barrier |
| Q35176185 | EphrinB1: novel microtubule associated protein whose expression affects taxane sensitivity |
| Q33720063 | Estramustine resistance |
| Q41021424 | Estramustine resistance correlates with tau over-expression in human prostatic carcinoma cells |
| Q40242568 | Evidence that a single monolayer tubulin-GTP cap is both necessary and sufficient to stabilize microtubules |
| Q37238270 | Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments |
| Q38338083 | Expression of specific tau exons in normal and tumoral pancreatic acinar cells |
| Q43519306 | FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells |
| Q30485126 | FTDP-17 mutations in Tau alter the regulation of microtubule dynamics: an "alternative core" model for normal and pathological Tau action. |
| Q33703950 | Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies |
| Q26777247 | Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations |
| Q24651392 | Functional MAPT haplotypes: bridging the gap between genotype and neuropathology |
| Q43662734 | Functional differences of tau isoforms containing 3 or 4 C-terminal repeat regions and the influence of oxidative stress |
| Q37384897 | Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly |
| Q34081720 | GSK3β is involved in the relief of mitochondria pausing in a Tau-dependent manner |
| Q43790570 | GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity |
| Q38680881 | Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins. |
| Q34574931 | Genetics of frontotemporal lobar degeneration |
| Q81651149 | Genetics of progressive supranuclear palsy |
| Q50573557 | Heterogeneous Tau-Tubulin Complexes Accelerate Microtubule Polymerization |
| Q34388804 | High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands |
| Q39612660 | High-Content RNA Interference Assay: Analysis of Tau Hyperphosphorylation as a Generic Paradigm |
| Q33523403 | High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation |
| Q50921086 | Human MAP Tau Based Targeted Cytolytic Fusion Proteins |
| Q34166270 | Identification of Stk25 as a genetic modifier of Tau phosphorylation in Dab1-mutant mice |
| Q41186950 | Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity |
| Q47839793 | Insights into tau function and dysfunction through single-molecule fluorescence. |
| Q22253456 | Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments |
| Q28345884 | Isolation and characterization of kinase interacting protein 1, a pollen protein that interacts with the kinase domain of PRK1, a receptor-like kinase of petunia |
| Q52044711 | Kinase and phosphatase inhibitors cause rapid alterations in microtubule dynamic instability in living cells |
| Q27027026 | Lessons from in vitro reconstitution analyses of plant microtubule-associated proteins |
| Q34177990 | Loss of Hsp110 Leads to Age-Dependent Tau Hyperphosphorylation and Early Accumulation of Insoluble Amyloid β |
| Q34938739 | Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity. |
| Q41986825 | MAP2-mediated in vitro interactions of brain microtubules and their modulation by cAMP. |
| Q55068033 | MAPs, MARKs and microtubule dynamics. |
| Q24313701 | MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption |
| Q37544756 | Mechanism-based treatments for Alzheimer's disease |
| Q52583374 | Microtubule binding of the drosophila DMAP-85 protein is regulated by phosphorylation in vitro |
| Q28259930 | Microtubule polymerization dynamics |
| Q41471811 | Microtubule-associated protein tau promotes neuronal class II β-tubulin microtubule formation and axon elongation in embryonic Xenopus laevis. |
| Q28576082 | Microtubule-dependent oligomerization of tau. Implications for physiological tau function and tauopathies |
| Q26865234 | Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease |
| Q38607493 | Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease |
| Q48406119 | Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease |
| Q30593774 | Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration |
| Q39925326 | Modulation of microtubule dynamics by the microtubule-associated protein 1a. |
| Q41809018 | Modulation of tau phosphorylation and intracellular localization by cellular stress |
| Q46308115 | Molecular events during the induction of neurodegeneration and memory loss in estrogen-deficient rats |
| Q34573160 | Mutations of a redundant alpha-tubulin gene affect Caenorhabditis elegans early embryonic cleavage via MEI-1/katanin-dependent and -independent pathways |
| Q36840854 | Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms |
| Q26747418 | NMR Meets Tau: Insights into Its Function and Pathology |
| Q88633383 | Near-atomic model of microtubule-tau interactions |
| Q52613291 | Novel monoclonal antibodies targeting the microtubule-binding domain of human tau. |
| Q28116297 | Nuclear tau, a key player in neuronal DNA protection |
| Q42575598 | Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action |
| Q28504627 | Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells |
| Q51835482 | Phenotypic consequences of beta1-tubulin expression and MAP4 decoration of microtubules in adult cardiocytes |
| Q28278995 | Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics |
| Q42028884 | Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly |
| Q60603639 | Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain |
| Q48594422 | Phosphorylation regulates the microtubule‐destabilizing activity of stathmin and its interaction with tubulin |
| Q40784600 | Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2. |
| Q24302556 | Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules |
| Q39873721 | Propagation of tau misfolding from the outside to the inside of a cell. |
| Q38154973 | Propagation of tau pathology in Alzheimer's disease: identification of novel therapeutic targets |
| Q34283149 | Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease |
| Q48472306 | Purification of a WD Repeat Protein, EMAP, That Promotes Microtubule Dynamics through an Inhibition of Rescue |
| Q37751240 | Quantitative analysis of MAP-mediated regulation of microtubule dynamic instability in vitro focus on Tau. |
| Q48687953 | Rapid Alteration of Tau in Oligodendrocytes After Focal Ischemic Injury in the Rat: Involvement of Free Radicals |
| Q89411641 | Recent Insights on Alzheimer's Disease Originating from Yeast Models |
| Q38061634 | Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's? |
| Q48137469 | Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells |
| Q42796132 | Regulation of microtubule dynamics by extracellular signals: cAMP-dependent protein kinase switches off the activity of oncoprotein 18 in intact cells. |
| Q34387412 | Regulation of microtubule-associated proteins. |
| Q35005870 | Regulation of microtubule-organizing center orientation and actomyosin cytoskeleton rearrangement during immune interactions |
| Q36394952 | Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity |
| Q24540276 | Repeat motifs of tau bind to the insides of microtubules in the absence of taxol |
| Q92856681 | Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects |
| Q48473074 | SCG10, a microtubule destabilizing factor, stimulates the neurite outgrowth by modulating microtubule dynamics in rat hippocampal primary cultured neurons |
| Q48134444 | Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo |
| Q39379363 | Spreading of Pathology in Alzheimer's Disease |
| Q39393192 | Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates |
| Q99579313 | Stem cell therapy for Alzheimer's disease |
| Q90468301 | Stress granules and neurodegeneration |
| Q42157648 | Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule‐binding repeats in filament nucleation |
| Q38674719 | Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly |
| Q38025629 | Tau Protein and Adult Hippocampal Neurogenesis |
| Q33957159 | Tau aggregation into fibrillar polymers: taupathies |
| Q34995112 | Tau and axonopathy in neurodegenerative disorders |
| Q27027415 | Tau and tauopathies |
| Q37297103 | Tau antagonizes end-binding protein tracking at microtubule ends through a phosphorylation-dependent mechanism. |
| Q36970350 | Tau as a therapeutic target in neurodegenerative disease |
| Q48292540 | Tau binding to microtubules does not directly affect microtubule-based vesicle motility |
| Q49787664 | Tau can switch microtubule network organizations: from random networks to dynamic and stable bundles. |
| Q30647952 | Tau co-organizes dynamic microtubule and actin networks |
| Q34730572 | Tau function and dysfunction in neurons: its role in neurodegenerative disorders |
| Q34163214 | Tau gene mutations: dissecting the pathogenesis of FTDP-17. |
| Q40052235 | Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: neurofilaments attenuate tau-mediated neurite instability |
| Q24314155 | Tau is enriched on dynamic microtubules in the distal region of growing axons |
| Q30493882 | Tau isoform regulation is region- and cell-specific in mouse brain. |
| Q82910022 | Tau isoform-specific modulation of kinesin-driven microtubule gliding rates and trajectories as determined with tau-stabilized microtubules |
| Q37129461 | Tau mediates microtubule bundle architectures mimicking fascicles of microtubules found in the axon initial segment |
| Q33674452 | Tau mutants bind tubulin heterodimers with enhanced affinity |
| Q33576693 | Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein |
| Q33844141 | Tau protein function in axonal formation |
| Q30962853 | Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells |
| Q64867839 | Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly |
| Q38611694 | The Endogenous and Cell Cycle-dependent Phosphorylation of tau Protein in Living Cells: Implications for Alzheimer’s Disease |
| Q42676809 | The TOGp protein is a new human microtubule-associated protein homologous to the Xenopus XMAP215 |
| Q46368794 | The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation. |
| Q34587678 | The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies |
| Q38610025 | The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains |
| Q36892893 | The effect of multivalent cations and Tau on paclitaxel-stabilized microtubule assembly, disassembly, and structure. |
| Q36968220 | The importance of tau phosphorylation for neurodegenerative diseases |
| Q34670832 | The leukocyte cytoskeleton in cell migration and immune interactions |
| Q47252107 | The microtubule binding of Tau and high molecular weight Tau in apoptotic PC12 cells is impaired because of altered phosphorylation |
| Q33515434 | The proline-rich domain of tau plays a role in interactions with actin |
| Q47361624 | The role of MAPT sequence variation in mechanisms of disease susceptibility |
| Q34348115 | The role of tau (MAPT) in frontotemporal dementia and related tauopathies |
| Q34138413 | The role of tau kinases in Alzheimer's disease |
| Q93050870 | Untangling the Conformational Polymorphism of Disordered Proteins Associated With Neurodegeneration at the Single-Molecule Level |
| Q36354014 | Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits |
| Q39994322 | Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models |
| Q33865050 | Wnt5a evokes cortical axon outgrowth and repulsive guidance by tau mediated reorganization of dynamic microtubules |
| Q41075668 | XMAP310: a Xenopus rescue-promoting factor localized to the mitotic spindle. |
| Q33890834 | ZipA is a MAP-Tau homolog and is essential for structural integrity of the cytokinetic FtsZ ring during bacterial cell division |
| Q40151433 | p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells |
Search more.